Short Note on Receptors
... is a drug that does not provoke a biological response itself upon binding to a receptor, but blocks or attenuates agonist-mediated responses. In pharmacology an antagonist is a binding partner (ligand) of a receptor by disrupting the interaction and inhibiting the function of an agonist or inverse a ...
... is a drug that does not provoke a biological response itself upon binding to a receptor, but blocks or attenuates agonist-mediated responses. In pharmacology an antagonist is a binding partner (ligand) of a receptor by disrupting the interaction and inhibiting the function of an agonist or inverse a ...
Anti Histamin H 1 receptor antagonists
... • Topical capsaicin acts through TRPV1 (transient-receptor potential vanilloid receptor-1 ) expressed on sensory skin nerves to release neuropeptides such as substance P. • TRPV1 recently has been implicated in the pathogenesis of pruritus and thus may be the target through which capsaicin exerts it ...
... • Topical capsaicin acts through TRPV1 (transient-receptor potential vanilloid receptor-1 ) expressed on sensory skin nerves to release neuropeptides such as substance P. • TRPV1 recently has been implicated in the pathogenesis of pruritus and thus may be the target through which capsaicin exerts it ...
Centrally Acting Agents
... Methyldopa is incompletely absorbed after oral administration and undergoes extensive hepatic and pre-hepatic metabolism to form metabolites, some of which are active. The elimination halflife of the parent drug is about two hours. Moxonidine has pharmacokinetics very similar to those of clonidine b ...
... Methyldopa is incompletely absorbed after oral administration and undergoes extensive hepatic and pre-hepatic metabolism to form metabolites, some of which are active. The elimination halflife of the parent drug is about two hours. Moxonidine has pharmacokinetics very similar to those of clonidine b ...
INSUFICIÊNCIA CARDÍACA
... when administered in a long-acting form" Develops with all nitrates Is dose-dependent Disappears in 24 h. after stopping the drug Tolerance can be avoided - Using the least effective dose - Creating discontinuous plasma levels ...
... when administered in a long-acting form" Develops with all nitrates Is dose-dependent Disappears in 24 h. after stopping the drug Tolerance can be avoided - Using the least effective dose - Creating discontinuous plasma levels ...
Alfuzosin用於治療女性case之討論
... decrease outflow obstruction and irritation symptoms, such as frequency, nocturia, urgency, and urge incontinence, associated with BPH. • Alfuzosin is a selective α-1 adrenoceptor antagonist. Alfuzosin bears structural similarity to prazosin, and both are quinazoline derivatives. In vitro and in viv ...
... decrease outflow obstruction and irritation symptoms, such as frequency, nocturia, urgency, and urge incontinence, associated with BPH. • Alfuzosin is a selective α-1 adrenoceptor antagonist. Alfuzosin bears structural similarity to prazosin, and both are quinazoline derivatives. In vitro and in viv ...
Opioid Anelgesics
... Effects of specific opioid drugs depend on the receptor subtype with which they interact as ...
... Effects of specific opioid drugs depend on the receptor subtype with which they interact as ...
